Homepage
Inhibiting HIV by Host Cell Targeting Strategies
amfAR-funded researchers help identify two small antibodies that work to target host cells and inhibit HIV growth.
Government Mandates Insurers Cover Long-Acting PrEP and Contraceptives
The rule changes require insurers to cover fully the cost of over-the-counter contraceptives and long-acting injectable PrEP for HIV prevention.
Supporting People-Centered Hepatitis B Care
TREAT Asia’s fact sheet provides a guide to the latest gold-standard approaches to chronic hepatitis B prevention, care, diagnosis, and treatment.
Leading the Way to a Cure
amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has raised nearly $900 million in support of its programs and has awarded more than 3,800 grants to research teams worldwide.
Research Grants
amfAR utilizes formal requests for proposals to solicit grant applications for both targeted and general HIV/AIDS research. Proposals are then peer reviewed by the Scientific Advisory Committee on the basis of their relevance, scientific merit, and promise. To date, amfAR has awarded more than 3,800 grants to research teams worldwide.
Research Grants Awarded
Requests for Proposals
Donate to amfAR: Fuel Lifesaving Research
Make your contribution today and join the fight to #CureAIDS. Your support contributes to the advancement of amfAR’s cutting-edge HIV/AIDS research.
Show the world that a cure isn’t just possible—it’s within reach.